title: The role of the CC chemokine, RANTES, in acute lung allograft rejection.
abstract: Lung transplantation is a therapeutic option for patients with end-stage lung disease. Acute allograft rejection is a major complication of lung transplantation and is characterized by the infiltration of activated mononuclear cells. The specific mechanisms that recruit these leukocytes have not been fully elucidated. The CC chemokine, RANTES, is a potent mononuclear cell chemoattractant. In this study we investigated RANTES involvement during acute lung allograft rejection in humans and in a rat model system. Patients with allograft rejection had a 2.3-fold increase in RANTES in their bronchoalveolar lavages compared with healthy allograft recipients. Rat lung allografts demonstrated a marked time-dependent increase in levels of RANTES compared with syngeneic control lungs. RANTES levels correlated with the temporal recruitment of mononuclear cells and the expression of RANTES receptors CCR1 and CCR5. To determine RANTES involvement in lung allograft rejection, lung allograft recipients were passively immunized with either anti-RANTES or control Abs. In vivo neutralization of RANTES attenuated acute lung allograft rejection and reduced allospecific responsiveness by markedly decreasing mononuclear cell recruitment. These experiments support the idea that RANTES, and the expression of its receptors have an important role in the pathogenesis of acute lung allograft rejection.
authors.affiliation: Department of Medicine, University of California School of Medicine, Los Angeles 90095, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Belperio
authors.forename: M D
authors.initials: MD
authors.lastname: Burdick
authors.forename: M P
authors.initials: MP
authors.lastname: Keane
authors.forename: Y Y
authors.initials: YY
authors.lastname: Xue
authors.forename: J P
authors.initials: JP
authors.lastname: Lynch
authors.forename: B L
authors.initials: BL
authors.lastname: Daugherty
authors.forename: S L
authors.initials: SL
authors.lastname: Kunkel
authors.forename: R M
authors.initials: RM
authors.lastname: Strieter
mesh_terms: D000208:Acute Disease; D000818:Animals; D002465:Cell Movement / Q000276:immunology; D018946:Chemokine CCL5 / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D006084:Graft Rejection / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D008168:Lung / Q000276:immunology / Q000378:metabolism; D016040:Lung Transplantation / Q000276:immunology* / Q000473:pathology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000378:metabolism; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D054389:Receptors, CCR1; D019713:Receptors, CCR5 / Q000096:biosynthesis; D019707:Receptors, Chemokine / Q000096:biosynthesis; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: C515300:CCR1 protein, human; C515302:Ccr1 protein, rat; D018946:Chemokine CCL5; D007106:Immune Sera; D012333:RNA, Messenger; D054389:Receptors, CCR1; D019713:Receptors, CCR5; D019707:Receptors, Chemokine